Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 10 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026 and Sep 2026.
- Largest single sale: $372K (3,320 shares) of Oruka Therapeutics, Inc. on Aug 17, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Chief Medical Officer | Sep 6, 2024 | Sep 15, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 15, 2026, Oruka Therapeutics, Inc.: sold 7,947 shares for $734K, under a disclosed plan; 7,000 shares acquired by exercising options. 1 filing: 1
- Aug 17, 2026, Oruka Therapeutics, Inc.: sold 7,000 shares for $783K, under a disclosed plan; 7,000 shares acquired by exercising options. 1 filing: 1
- Jul 15, 2026, Oruka Therapeutics, Inc.: sold 7,000 shares for $604K, under a disclosed plan; 7,000 shares acquired by exercising options. 1 filing: 1
- Jun 15, 2026, Oruka Therapeutics, Inc.: sold 7,947 shares for $551K, under a disclosed plan; 7,000 shares acquired by exercising options. 1 filing: 1
- May 15, 2026, Oruka Therapeutics, Inc.: sold 7,000 shares for $433K, under a disclosed plan; 7,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.